Steve Cohen runs the $39 billion hedge fund Point72 Asset Management and was famously dubbed the "hedge fund king" in 2006.

To get a sense of who is truly in control of Immunome, Inc. (NASDAQ:IMNM), it is important to understand the ownership structure of the business. We can see that institutions own the lion's share in ...

The financial strain on hedge funds was brewing for weeks. Millennium Management, a major player with approximately $75 ...

Early monthly returns for large multistrategy firms Millennium and Point72 show industry-wide pain thanks to market ...

Bank of New York Mellon Corp reduced its stake in Kronos Worldwide, Inc. (NYSE:KRO – Free Report) by 23.2% during the fourth ...

Gradial, a Seattle startup that uses AI agents to help marketing operations teams increase productivity, raised $13 million ...

Analysts at StockNews.com assumed coverage on shares of Triumph Group (NYSE:TGI – Get Free Report) in a research note issued ...

If Elon Musk were to get his way, President Donald Trump would preside over an economic overhaul befitting a fellow 1980s ...

Seattle-based startup sees 30x revenue growth as enterprises adopt its agentic platform to revolutionize content supply chains and digital marketing< ...

Trump administration policies Billionaire hedge fund boss Steve Cohen is bearish on the U.S. markets and blames the policies ...

Renowned hedge fund manager Steven Cohen recently made headlines with his bold prediction regarding an imminent peak in the financial ...

Multi-strategy hedge funds are facing their biggest challenge since the early days of the pandemic amid a market sell-off ...